Beth Freeland, B.S. - Senior Project/Finance Manager
Beth Freeland, B.S.
Beth has 10 years of experience in the pharmaceutical industry in both research and cGMP manufacturing environments. Her experience has spanned early and late phase drug development where she has supported both oral and inhaled dosage forms, including device-based products.
She joins Velesco as an Analytical Scientist after nearly six years with Pfizer Global Research & Development. Beth previously worked in the Pharmaceutical Sciences Division in Ann Arbor, Michigan where she developed and validated analytical methods to support active pharmaceutical ingredient (API) and drug product development from pre-candidate to Phase II clinical studies. In 2007, she transferred to Sandwich, England where she provided extensive analytical support for the formulation development of a dual therapy inhalation drug product in late stage development.
Beth holds a Bachelor of Science degree in Physiology from Michigan State University and is a member of the American Chemical Society (ACS).
News and Events
Lisa Crandall, MS, and Peter Angus, PhD, spoke with Pharmaceutical Technology about the best practices in stability testing. Read the interview here.
Velesco has expanded our analytical facilities in a new Wixom, Michigan location with the help of the Bank of Ann Arbor Technology Industry Group. Read the press release here.
CEO Dave Barnes has been published in a new Pharmoutsourcing article on Clinical Trial Materials and Manufacturing!
2 new job postings! Careers
Velesco's work published
Formulation Development & Manufacturing:
Using a Single Provider Reduces Costs & Risk
Read it here.